Cronos Group Inc. (NASDAQ:CRON) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Cronos Group Inc. (NASDAQ:CRONFree Report) by 14.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 231,965 shares of the company’s stock after selling 39,211 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cronos Group were worth $508,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CRON. Quantbot Technologies LP purchased a new position in Cronos Group in the third quarter valued at about $37,000. Intact Investment Management Inc. lifted its position in Cronos Group by 89.1% in the 3rd quarter. Intact Investment Management Inc. now owns 377,890 shares of the company’s stock valued at $836,000 after purchasing an additional 178,100 shares during the last quarter. International Assets Investment Management LLC raised its stake in Cronos Group by 119.0% during the 3rd quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after acquiring an additional 22,628 shares in the last quarter. Mackenzie Financial Corp acquired a new stake in Cronos Group in the second quarter worth about $3,237,000. Finally, Cedar Wealth Management LLC grew its holdings in Cronos Group by 65.4% during the second quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock worth $88,000 after acquiring an additional 15,000 shares during the period. 8.71% of the stock is owned by institutional investors and hedge funds.

Cronos Group Price Performance

Cronos Group stock opened at $1.95 on Friday. The firm’s 50 day simple moving average is $2.08 and its 200-day simple moving average is $2.22. The company has a market cap of $745.48 million, a P/E ratio of -15.00 and a beta of 0.99. Cronos Group Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $3.14.

Cronos Group Profile

(Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Featured Articles

Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc. (NASDAQ:CRONFree Report).

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.